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ABSTRACT  
 
We evaluated the expression and function of the microglia-specific growth factor, 
Progranulin-a (Pgrn-a) during developmental neurogenesis in the embryonic retina of 
zebrafish. At 24 hpf pgrn-a is expressed throughout the forebrain, but by 48 hpf pgrn-a 
is exclusively expressed by microglia and/or microglial precursors within the brain and 
retina. Knockdown of Pgrn-a does not alter the onset of neurogenic programs or 
increase cell death, however, in its absence, neurogenesis is significantly delayed - 
retinal progenitors fail to exit the cell cycle at the appropriate developmental time and  
postmitotic cells do not acquire markers of terminal differentiation, and microglial 
precursors do not colonize the retina. Given the link between Progranulin and cell cycle 
regulation in peripheral tissues and transformed cells, we analyzed cell cycle kinetics 
among retinal progenitors following Pgrn-a knockdown. Depleting Pgrn-a results in a 
significant lengthening of the cell cycle. These data suggest that Pgrn-a plays a dual 
role during nervous system development by governing the rate at which progenitors 
progress through the cell cycle and attracting microglial progenitors into the embryonic 
brain and retina. Collectively, these data show that Pgrn-a governs neurogenesis by 
regulating cell cycle kinetics and the transition from proliferation to cell cycle exit and 
differentiation.   
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INTRODUCTION 
 Progranulin (PGRN), also known as granulin-epithelin precursor, acrogranin, 
proepithelin and PC cell-derived growth factor, is an evolutionarily conserved secreted 
growth factor/pleiotropic glycoprotein precursor with a well-established role in 
embryogenesis, tumorigenesis and wound healing (He and Bateman, 2003; He et al., 
2003; Ong and Bateman, 2003). In peripheral tissues and tumor cells, PGRN is 
mitogenic, stimulates cell proliferation and migration, and promotes cell survival (He et 
al., 2002; He and Bateman, 2003; Ong and Bateman, 2003). In the mammalian CNS, 
PGRN is expressed by neurons and microglia (Daniel et al., 2000). In humans, 
diminished PGRN production due to heterozygous mutations in the PGRN gene (hGRN) 
is a major cause of the neurodegenerative disease, Frontotemporal Lobar Degeneration 
(Baker et al., 2006; Cruts et al., 2006). In contrast, malignancy of glioblastomas is 
correlated with elevated PGRN levels (Liau et al., 2000; Wang et al., 2011). In vivo, 
PGRN increases exercise-induced neurogenesis in the hippocampus of adult mice 
(Asakura et al., 2011). In vitro, PGRN enhances neuronal survival, increases neural 
progenitor proliferation, and promotes neurite outgrowth and neuronal differentiation 
(Van Damme et al., 2008; Ryan et al., 2009; Gao et al., 2010; Nedachi et al., 2011). 
Modulation of PGRN levels is a molecular signature of activated microglia (De Muynck 
and Van Damme, 2011); CNS injury induces a microglia-specific upregulation of 
progranulin mRNA and protein synthesis (Craig et al., 2008; Moisse et al., 2009; 
Naphade et al., 2009; Philips et al., 2010). Interestingly, in vitro PGRN acts as a 
microglial chemoattractant (Pickford et al., 2011). Much is known about PGRN activity in 
non-neuronal tissues and the injured CNS, however the function of PGRN within the 
developing CNS is not well understood. 
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We use the zebrafish retina as a model tissue for studying brain development. 
The vertebrate retina is a well-established and tractable model for investigating the 
cellular and molecular mechanisms that regulate both developmental and regenerative 
neurogenesis (Agathocleous and Harris, 2009). Among vertebrates, the cytoarchitecture 
of the retina is precise and evolutionarily very highly conserved. Even subtle changes in 
developmental programs are easily detected as structural changes (Cepko et al., 1996). 
Zebrafish have four protein-encoding progranulin genes, two of which, pgrn-a and pgrn-
b, are co-orthologues of mammalian gene (GRN) (Cadieux et al., 2005). pgrn-a is 
syntenically conserved, making it the true orthologue of hGRN. We first identified pgrn-a 
as a microglia-specific growth factor in the retina of the adult zebrafish, where it is 
strongly upregulated following photoreceptor death and during photoreceptor 
regeneration (Craig et al., 2008).  
To test the hypothesis that the microglia-specific growth factor, Pgrn-a, regulates 
neurogenesis in the vertebrate retina, we evaluated its developmental expression and 
used protein knockdown to test its function. At 24 hours post fertilization (hpf), pgrn-a is 
expressed throughout the forebrain, but beginning about 36hpf pgrn-a expression 
becomes limited to macrophages/microglial precursors in the yolk sac, brain and retina. 
Knockdown of Pgrn-a using morpholino oligonucleotides results in marked 
developmental changes. In morphants, retinal development is delayed; retinal 
progenitors remain in the cell cycle at times when they are normally postmitotic, and 
there is a corresponding absence of neuronal differentiation. Further, depletion of Pgrn-
a prevents microglial precursors from migrating into the retina. Given that PGRN 
governs the cell cycle in peripheral tissues and transformed cells (Ong and Bateman, 
2003), we evaluated cell cycle kinetics in retinal progenitors following Pgrn-a 
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knockdown. Depleting Pgrn-a significantly increases the duration of the G2- and M-
phases, and this results in an overall increase in the total length of the cell cycle. We 
also found that diminished Pgrn-a results in a significant increase in the expression of 
genes that promote cell cycle progression, and a significant reduction in the expression 
of genes that promote cell cycle exit, demonstrating that Pgrn-a signaling regulates the 
duration of the cell cycle by governing the expression of genes that directly control cell 
cycle progression. From these data, we conclude that the microglia-specific molecule, 
Pgrn-a, plays fundamental role in governing developmental neurogenesis. Further, we 
conclude that Pgrn-a also functions to recruit microglial precursors to the embryonic 
CNS.  
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MATERIALS AND METHODS 
Animals 
Adult AB wild type (WT) zebrafish (Danio rerio; ZIRC, University of Oregon, Eugene, 
OR, USA) were maintained at 28.5°C on a 14/10-h light/dark cycle. Embryos were 
collected immediately following natural spawns, incubated at 28.5°C on a 14/10-h 
light/dark cycle and staged by hours post fertilization (hpf). The Institutional Animal Care 
and Use Committee at the University of Michigan approved all protocols and procedures.  
 
Immunohistochemistry (IHC) 
IHC was performed as previously described (Luo et al., 2012). Briefly, embryos were 
fixed overnight in 4% paraformaldehyde (PFA) in 100mM phosphate buffer at 4°C, 
cryoprotected with 20% sucrose in 100mM phosphate buffer, and embedded in frozen 
Tissue-Tek optical cutting temperature (OCT; Sakura Finetek USA Inc., Torrance, CA, 
USA) compound. Frontal sections (10µm thick), immediately adjacent to or including the 
optic nerve, were mounted on slides, washed, incubated in heat inactivated normal 
sheep serum (NSS; Sigma-Aldrich Corp., St. Louis MO, USA), and incubated overnight 
at 4˚C with primary antibodies. The following day, sections were washed and incubated 
in secondary antibodies for 1hr at room temperature.  Nuclei were stained with DAPI. 
The antibodies used and their concentrations are listed in Table S1. 
 
S-phase labels 
Cells in S-phase of the cell cycle were labeled with either 5-Bromo-2’deoxyuridine 
(BrdU; Sigma-Aldrich Corp., St. Louis, MO, USA) or 5-ethynyl-2’deoxyuridine (EdU; 
Invitrogen, Carlsbad, CA, USA) as previously described (Ochocinska and Hitchcock, 
2007; Luo et al., 2012). Briefly, dechorionated embryos at 24 and 48hpf were incubated 
for 20 minutes in ice-cold 10mM BrdU or 1.5mM EdU dissolved in E3 containing 15% 
DMSO. 72hpf embryos were incubated for 20 minutes in 10mM BrdU or 1.5mM EdU 
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dissolved in E3 containing 15% DMSO at room temperature (RT). 8dpf larvae were 
incubated for 20 minutes in 2mM EdU dissolved in 10% PBS in E3 at RT. Following the 
labeling step, embryos/larvae were returned to RT E3 for 10 minutes prior to fixation. 
For BrdU staining, sections were incubated in 100°C sodium citrate buffer (10mM 
sodium citrate, 0.05% Tween 20, pH 6.0) for 30 minutes, cooled to RT for 60 minutes, 
and then immunolabeled using standard protocols described above.  
In situ hybridization  
Double in situ hybridization (ISH) on retinal sections (Hitchcock and Kakuk-Atkins, 
2004) and whole mount ISH was performed as previously described (Hitchcock and 
Kakuk-Atkins, 2004; Ochocinska and Hitchcock, 2007; Craig et al., 2008; Luo et al., 
2012). Sense and antisense digoxigenin (DIG)- or fluorescein-labeled riboprobes (Table 
S2) were synthesized from full-length cDNA clones for pgrn-a (NM001001949; a gift 
from Dr. Hugh Bennett), fms (NM131672; a gift from Dr. Philippe Herbomel), and atoh7 
(NM131632; a gift from Dr. Deborah Stenkamp) using in vitro transcription (Roche 
Diagnostic Corp., Indianapolis, IN, USA). Embryos were incubated with hybridization 
solution containing approximately 100ng of probe. For double fluorescent in situ 
hybridization, the fms and pgrn-a probes were hybridized simultaneously. 
 
Pgrn-a Knockdown with Morpholino Oligonucleotides (MOs) 
For Pgrn-a knockdown, two independent antisense MOs (Gene Tools, LLC, Philomath, 
OR, USA), targeting either the 5’UTR (0.25ng/embryo) or the splice site between exon 3 
and intron 3 (SS, 1ng/embryo) of zebrafish pgrn-a, were diluted in 1X Danieau buffer 
(Nasevicius and Ekker, 2000) containing 2.5% phenol red and injected into the yolk of 
AB WT embryos at the 1-2 cell stage. 5-base pair mismatch (MM) and standard control 
(SC) MOs (Gene Tools, LLC, Philomath, OR, USA) were used as negative controls. To 
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suppress potential off target effects induced by experimental MOs, p53 MO (Gene Tools, 
LLC, Philomath, OR, USA) was co-injected (1.5 fold) to block nonspecific cell death 
(Robu et al., 2007). The MO sequences are listed in Table S3.  
 
mRNA Rescue  
The coding sequence of zebrafish (zf) pgrn-a (NM_001001949.2; in pSPORT1 Vector) 
and the pgrn-a paralog, zf pgrn-b (NM_212738.1; in pBK-CMV Image Clone from Open 
Biosystems, GE Dharmacon, Lafayette, CO, USA), were PCR amplified starting from 
the ATG (primer sequences listed in Table S4), therefore removing the 5’UTR MO 
recognition sequence, using Platinum Taq DNA Polymerase HF (Invitrogen, Carlsbad, 
CA, USA). cDNAs were subcloned into the pGEM-T Easy Vector (Promega, Madison, 
WI, USA) using standard protocols, linearized with SacI-HF (New England Biolabs, 
Ipswich, MA, USA), and capped RNAs were transcribed using the mMESSAGE 
mMACHINE T7 kit (Ambion, Thermo Fisher Scientific, Halethorp, MD, USA). Human 
progranulin (hGRN; GE Healthcare clone ID 3457813 in pCMV-SPORT6) and eGFP 
(pCS2+-EGFP) were linearized with NotI-HF and transcribed with SP6. For rescue 
experiments, zf pgrn-a (25pg/embryo), zf pgrn-b (25pg/embryo) or human progranulin 
(hGRN; 400pg/embryo) was co-injected with 5’UTR MO (.25ng/embryo) at the one cell 
stage. As a negative control, eGFP mRNA (25pg/embryo) was co-injected with the 
5’UTR MO (.25ng/embryo). At 72hpf Embryos were treated with EdU, sacrificed, and 
processed for IHC. 
 
Western Blot  
To confirm knockdown of Pgrn-a, Western blotting was performed as previously 
described (Gramage et al., 2015). Briefly, for each condition, protein was isolated from 
50 embryo heads and separated by gel electrophoresis. Proteins were transferred to 
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polyvinylidene difluoride (PVDF) membranes (GenHunter Corp., Nashville, TN, USA) 
and incubated with rabbit anti-Pgrn antibodies (1:2000, a gift from Jen Leih Wu), see Li 
et al., 2010). The polyclonal anti-PgrnA antibodies were raised against a peptide that 
corresponds to residues 244-264, which are unique to PgrnA (Li et al., 2010). 
Immunolabeled proteins were detected using enhanced chemiluminescence assay 
(ECL detection system, Amersham Biosciences, Arlington Heights, IL, USA). Anti-Actin 
(1:1000, Calbiochem, EMD Millipore, Billerica, MA, USA) was used as a loading control.  
 
PCR 
To verify SS-targeting MOs altered processing of pgrn-a pre-mRNA, PCR was 
performed on RNA isolated from SS morphant and uninjected control embryos at 48hpf. 
cDNA was reverse transcribed using the SuperScript kit (Invitrogen, Carlsbad, CA, 
USA). Primers flanking the SS MO target sequence (F: AGAATGTTGTGAGGACCATC 
and R: CTGTGCTACTGGACAGCAG) were used to amplify the pgrn-a locus following 
manufacturer’s protocol (SuperScript One-Step RT-PCR system; Invitrogen). PCR 
products were separated by gel electrophoresis, purified and sequenced.  
 
Cell Cycle Kinetics 
Mitotic Index 
The proportion of cells in the M-phase of the cell cycle was determined for embryos at 
28hpf Retinal sections were immunolabeled with anti-phosphorylated histone H3 (pH3), 
marking cells in the M-phase, and the number of M-phase cells as a function of retinal 
area (um2) was calculated. The spatial pattern of pH3 labeled cells was also assessed.  
Percent Labeled Mitosis  
The length of the G2-phase of the cell cycle was determined using the percent labeled 
mitosis technique (Quastler and Sherman, 1959; Luo et al., 2012). Embryos at 28hpf 
were incubated in BrdU for 20 minutes to label all cells in the S-phase of the cell cycle. 
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Starting 10 minutes after BrdU exposure, embryos were collected at 30-minute intervals 
through 35hpf, sectioned and immunolabeled with anti-pH3 and anti-BrdU antibodies. 
The proportion of double-labeled retinal cells ((pH3+BrdU+)/(pH3+)) was plotted as a 
function of time following BrdU exposure.  
Pulse-Chase-Pulse  
To determine the relative length of S-phase (Ts) and estimate the total cell cycle length 
(Tc), a pulse chase pulse method was used as previously described (Rachel et al., 
2002). At 26hpf, embryos were incubated in 10mM BrdU dissolved in E3 containing 
15% DMSO for 20 minutes on ice, rinsed in E3 at RT, incubated in 10mM thymidine at 
28.5°C for 20 minutes (Otteson et al., 2001), washed in E3 for 1hr 40 minutes at 28.5°C 
and incubated in 1.5mM EdU dissolved in E3 containing 15% DMSO for 20 minutes on 
ice. Embryos were then rinsed for an additional 10 minutes, sacrificed and processed 
sequentially to label BrdU and EdU. Nuclei were counterstained with DAPI. For each 
embryo, an optical section from the middle of a z-stack taken of one central retina 
section was selected and cells labeled with BrdU (nBrdU), EdU (nEdU) and DAPI 
(nDAPI) were counted. The length of the S-phase and total length of the cell cycle were 
determined using the following formulae, Ts=2/(nBrdU+/ntotal EdU+) and Tc=Ts/(nEdU+/nDAPI+), 
respectively.  
 
Reverse transcriptase quantitative real-time PCR (qRT-PCR) for cyclins (B, D, and 
E) and cyclin-dependent kinase inhibitors (p27kip and p57kip) 
To determine the expression levels of genes that regulate cell cycle, qRT-PCR was 
performed as previously described (Taylor et al., 2015). For each condition, three 
biological replicates of 50 embryo heads were collected. Total RNA was isolated from 
pooled heads using the Aurum Total RNA Mini Kit (Bio-Rad Laboratories Inc., Hercules, 
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CA, USA). cDNA was synthesized using the QuantiTect Reverse Transcription kit 
(Qiagen, Hilden, Germany). Three technical replicates of each biological replicate were 
run in a Bio-Rad CFX384 Touch Real Time PCR Detection System using 6ng cDNA 
and Bio-Rad IQ SYBR Green Supermix. Primers are listed in Table S5. Gene 
expression was calculated using Bio-Rad CFX Manager Software and normalized to -
actin.    
 
Statistical Analysis 
Quantitative data was represented by means and standard deviations. To calculate 
statistical significance, a one-way ANOVA or Student’s t-test was used (GraphPad 
Prism Software, La Jolla, CA, USA). A p-value ≤ 0.05 was considered significant, unless 
otherwise noted. With the exception of the data presented in Figure 5C, F and G, 95% 
confidence intervals (CI) were calculated and reported here for all statistical 
comparisons.  
 
Imaging 
All sectioned material was sealed with glass coverslips and mounting media (Electron 
Microscopy Sciences, Hatfield, PA, USA). Fluorescence images were captured using a 
Leica TCS SP5 confocal microscope (Leica, Wetzler, Germany). Bright field images 
were captured using either a Leica DM6000 CFS or Leica M165FC microscope (Leica, 
Wetzler, Germany).  
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RESULTS 
 
Developmental expression of pgrn-a 
 We identified pgrn-a in the zebrafish retina through an unbiased screen for genes 
modulated during neuronal regeneration (see 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13999), and determined that in 
the adult retina pgrn-a is expressed exclusively by microglia (Craig et al., 2008). Based 
on these data and the observation that, in vitro, Pgrn is a chemoattractant to microglia 
(Pickford e  al., 2011), we hypothesized that Pgrn-a plays a fundamental role in 
developmental neurogenesis, and may also regulate the migration of microglial 
precursors from their origins in the yolk sack into neuroepithelial tissues. We first 
established the developmental cellular pattern of pgrn-a expression using in situ 
hybridization (Fig. 1, Fig. S1). At 24hpf, pgrn-a is expressed throughout the forebrain 
and retina (Fig. 1 A, S 1A). Between 24 and 48hpf, however, pgrn-a expression is down 
regulated in the neuroepithelium and becomes restricted to putative 
macrophages/microglial precursors in the yolk sac, forebrain and retina (arrowheads, 
Fig. 1 B-D, Fig. S1 B-E). There are no antibodies that detect zebrafish Pgrn-a in tissue 
sections, however, Western blot analysis showed that Pgrn-a is present at 24hpf (Fig. 
S1 E), suggesting that the protein is reliably expressed when transcript is present. To 
confirm that pgrn-a expressing cells in the embryonic retina are microglia, pgrn-a ISH 
was combined with immunstaining using the microglial markers, L-plastin (Herbomel 
and Levraud, 2005) and 4C4 (Raymond et al., 2006), and double ISH was perfomed 
using a probes for pgrn-a and fms, which encodes the macrophage colony stimulating 
factor 1 receptor (CSF1R). In the retina, all cells that express pgrn-a (Fig. 1 E,G) are co-
labeled with antibodies to L-plastin (Fig. 1 F) or 4C4 (Fig. 1 H) and co-express fms (Fig. 
1 I-L). Equivalent labeling patterns were observed in the brain (data not shown). 
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Knockdown of Pgrn-a results in diminished neuronal differentiation and a paucity 
of microglia  
 Two independent antisense MOs were used to block Pgrn-a synthesis. The 
ability to knockdown Pgrn-a with the 5’UTR-targeting MO was confirmed with Western 
blot analysis (Fig. 2 A-B). Diagnostic PCR showed that the SS-targeting MO resulted in 
intron retention and a premature stop codon (data not shown). There were no qualitative 
changes in the appearance of morphant retinas between 48 and 72hpf, so only data 
from 72hpf embryos are described here. At 72hpf, the overall body length and shape of 
control embryos (Fig. 2 D-F) and pgrn-a morphants (Fig. 2 G-H) are comparable to 
uninjected WT embryos (Fig. 2 C). In contrast to controls, pgrn-a morphants have 
markedly small forebrains and microphthalmia.  
Compared to warm blooded vertebrates, retinal morphogenesis in zebrafish is 
very rapid. By 24hpf, eyecups have formed from the anterior neural plate, and the retina 
consists of proliferating neuroepithelial cells (Schmitt and Dowling, 1994; 1996; Li et al., 
2000). At approximately 28hpf, neuronal differentiation begins and ganglion cells are the 
first to exit the cell cycle in a small ventronasal patch (Hu and Easter, 1999). Neuronal 
differentiation and lamination then progress sequentially from the ventronasal patch 
through each cellular lamina in circumferential waves that move dorsally, then 
temporally (Schmitt and Dowling, 1996; 1999; Hitchcock and Raymond, 2004). By 72hpf, 
the initial phase of neurogenesis is largely complete, and the retina is fully laminated 
and functional (Easter and Nicola, 1996). Beyond 72hpf and into adulthood, the retina 
continues to grow by expansion and the addition of new neurons from the ciliary 
marginal zone (CMZ; (Hitchcock et al., 2004; Raymond et al., 2006).  
To determine the functional consequences of Pgrn-a knockdown, qualitative and 
quantitative measures of cell proliferation, neuronal differentiation and retinal size were 
Page 13 of 42
John Wiley & Sons, Inc.
Developmental Neurobiology
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 14
compared between control and experimental groups at 72hpf (Fig. 3). At 72hpf, in 
retinas from uninjected embryos, EdU-positive progenitors are relatively few in number 
(Fig. 3 A-C, T) and restricted to the CMZ (brackets, Fig. 3 A). In the central retina, the 
absence of EdU reflects exit from the cell cycle prior to EdU exposure by neurons in the 
ganglion cell layer and the inner and outer nuclear layers (Fig. 3 A-C). Nuclear staining 
with DAPI reveals the retina is fully laminated, and, reflecting its functional state, 
markers of mature neurons label differentiated ganglion cells (Fig. 3 A), amacrine cells 
(Fig. 3 B), and photoreceptors (Fig. 3 C). All embryos injected with control MOs (Fig. 3 
D-L) appear identical to uninjected embryos (Fig. 3 A-C). In marked contrast to 
uninjected and control embryos, blocking the translation of Pgrn-a results in striking 
changes in the retinal phenotype. Compared to controls (Fig. 3 A-L), morphant retinas 
contain significantly more EdU-positive progenitors, which are present throughout the 
retina, and they lack well-defined laminae and differentiated neurons (Fig. 3 M-R). The 
microphthalmia observed in the whole mount embryos (Fig. 2 A-F) is readily observable 
in retinal sections (Fig. 3 M-R). As is also evident in the whole embryos, the retinal 
phenotype in the 5’UTR morphants is slightly more severe than the SS morphants. We 
interpret this to be a dose-dependent effect resulting from the SS MO targeting zygotic 
transcripts only, whereas the 5’UTR MO targets both maternal and zygotic transcripts 
(Cadieux et al., 2005; Bill et al., 2009). (All data presented below use the 5’UTR-
targeting MO). Collectively, these data show that the absence of Pgrn-a results in a 
significant temporal delay in retinal neurogenesis. Progenitors fail to exit the cell cycle at 
the appropriate developmental time, and among postmitotic neurons there is diminished 
differentiation. Interestingly, the number of retinal microglia was also significantly 
decreased in pgrn-a morphants compared to controls (Fig. 3 U). 
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MO concentrations decrease with each cell division, and, as a result, MO-
dependent inhibition of protein translation lasts approximately 3-4 dpf (Nasevicius and 
Ekker, 2000). Therefore, we also evaluated the potential for the recovery of retinal 
development in pgrn-a morphants. When morphants are allowed to survive to 8 dpf, 
Pgrn-a synthesis recovers and the cellular differentiation and cytoarchitecture of the 
retina follow normal developmental patterns (Fig. S2 A), however, the retinal size does 
not recover to control values (Fig. S2 B). This indicates that the recovery of Pgrn-a 
synthesis does not produce a compensatory acceleration of cell division or neuronal 
differentiation that would produce a retina of normal size. So too, the number of 
microglia in 8dpf larvae remains significantly below control values (Fig. S2 C).  
 
Neurogenic competence and cell death is not altered in morphants  
 Morpholino oligonucleotides have the potential to create spurious results from 
off-target effects (Eisen and Smith, 2008). As a first of several approaches to assess 
this, we determined whether or not the retinal changes observed here were due to a 
non-specific developmental delay. atoh7 is required to initiate neurogenesis and serves 
as an indicator of the onset of neurogenic competence (Masai et al., 2000; Kay, 2005). 
Pgrn-a knockdown does not alter the timing or spatial restriction of the initial atoh7 
expression (Fig. S3), though the apparent level of atoh7 expression in morphant larvae 
is diminished (cf. S3 A, B and C), indicating that the changes in retinal development are 
not a consequence of a simple, systemic developmental delay. Cell death is another 
potential off target affect. In embryos at 24 and 48hpf, counts of apoptotic cells marked 
by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL; Fig. S3D) or 
pyknotic nuclei labeled with acridine orange (data not shown) show no significant 
differences between control and experimental embryos, indicating that cell death cannot 
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account for the changes in retinal development. In addition, these data show that the 
presence of the p53 MO in both the MM and 5’UTR MOs does not artificially depress 
neuronal apoptosis between 28 and 72hpf. 
 
Co-injection of zf pgrn-a/b or hGRN mRNA rescues Pgrn-a knockdown 
 To validate the specificity of the Pgrn-a knockdown, mRNA encoding egfp, zf 
pgrn-a, zf pgrn-b, or hGRN was co-injected with the 5’UTR MO. To determine if 
exogenous mRNA rescued the knockdown phenotype, comparisons were made 
between embryos that were uninjected (Fig. 4 A-C), injected with 5’UTR MO alone (Fig. 
4 D-F), and co-injected with 5’UTR MO and one of the mRNA constructs (Fig. 4 G-O). 
As a control for the mRNA injections, the 5’UTR MO and egfp mRNA were co-injected, 
and this uniformly failed to rescue the developmental defects resulting from Pgrn-a 
knockdown (data not shown; Fig. 4 P-R). In contrast, both zebrafish pgrn paralogs and 
the human pgrn mRNA rescued the morpholino-induced developmental defects in 
retinal growth, cell proliferation and neuronal maturation. In these co-injected embryos, 
EdU-labeled retinal progenitors were present only in the CMZ, retinal laminae were fully 
formed, and retinal size was equal to controls (Fig. 4 G-O, P,Q). These data validate the 
specificity of the morpholinos targeted to pgrn-a, and demonstrate that Pgrn-a regulates 
both cell proliferation and neuronal differentiation. Finally, these experiments highlight 
the conserved function of progranulin protein between fish and humans. Interestingly, 
co-injecting mRNA only partially rescues the migration of macrophages/microglial 
precursors into the retina (Fig. 4 R). In embryos co-injected with Pgrn mRNA, the total 
number of retinal microglia is significantly increased compared to morphants, however, 
there are significantly fewer retinal microglia in co-injected embryos relative to 
uninjected controls (Fig. 4 R).  
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Pgrn-a knockdown alters cell cycle kinetics  
 In morphants, the persistence of retinal progenitors at a stage when these cells 
normally exit the cell cycle, suggests that Pgrn-a functions to promote progression 
through the cell cycle. Therefore, we determined the consequences of Pgrn-a 
knockdown on cell cycle kinetics using three approaches to directly measure the 
duration of individual components of the cell cycle and to estimate the total length of the 
cell cycle. First, the mitotic index was assayed at 28hpf. Sections through central retina 
were immunolabeled with anti-pH3, a marker of cells in M-phase, and the proportion of 
pH3-positive cells was determined. In the retina, cells divide at the apical surface of the 
neuroepithelium (Das et al., 2003; Baye and Link, 2007). Following Pgrn-a knockdown, 
the location of pH3-positive cells was similar in morphants and controls (Fig. 5 A), 
indicating that the fundamental polarization of the neuroepithelium and interkinetic 
nuclear migration is unchanged following knockdown of Pgrn-a (see Baye and Link, 
2007). In contrast, the number and proportion of M-phase cells was significantly less in 
the morphant retinas (Fig. 5 B).  
 Second, the length of the G2-phase of the cell cycle was determined using the 
Percent Labeled Mitosis method (Quastler and Sherman, 1959). This assay measures 
the interval between the S-phase, when cells can be labeled with BrdU, and when 
BrdU-positive cells undergo mitosis and become positive for pH3. The resulting curve 
represents the percentage of BrdU-labeled cells that are co-labeled with pH3 at each of 
the time points sampled. In control embryos, the percentage of double-labeled nuclei 
increases sigmoidally over time (Fig. 5 C; see Luo et al., 2012). For control groups, the 
curves plateau at 100% at about 2.5 hours, thereby defining the duration of the G2-
phase. In contrast, in Pgrn-a morphants, the curve is shifted to the right. There were 
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significantly fewer double-labeled cells at 60, 90, 120, 150, 300, and 330 minutes, 
indicating a G2-phase of about 3 hrs. Additionally, whereas the control curves begin to 
return to zero as BrdU-positive cells exit the M-phase and migrate away from the apical 
surface of the retina (Baye and Link, 2007), in morphant retinas the plateau at 100% 
persists, indicating that morphant progenitors are delayed in M. These cells eventually 
exit the M-phase and re-enter the cell cycle, because the number of progenitors does 
accumulate over time (cf. Fig. 3 P-R, Fig. 5 A). Together, these data show that 
knockdown of Pgrn-a results in a slower G2-phase and a prolongation of the M-phase.  
Third, a pulse chase pulse paradigm was used to determine the relative length of 
S-phase (TS) and estimate the total cell cycle length (TC) (Rachel et al., 2002). This 
analysis showed the duration of the S-phase (TS) is 6 hours (hrs) and is invariant in 
morphants and controls (Fig. 5 D). The total length of the cell cycle (TC) in uninjected 
controls is approximately 10hrs (Fig. 5 E), which recapitulates previous findings in WT 
embryos (see Nawrocki, 1985; Li et al., 2000). However, the TC in morphant retinas is 
approximately 14hrs, which is significantly greater than controls (Fig. 5 E).  These and 
the aforementioned PLM data reveal that the G1-phase is also longer in morphants 
(~5hrs) than in controls (~1.5hrs).  
To gain insight into the proximal molecular mechanisms that underlie control of 
the cell cycle by Pgrn-a, qRTPCR was performed at 30 and 72hpf to measure the 
expression levels of genes that promote cell cycle exit, e.g., p27kip and p57kip2 and 
genes that promote cell cycle progression, e.g., cyclin B, D1 and E. Compared to 
controls, at both 30 and 72hpf the expression level of p27kip is significantly lower in 
morphants (Fig. 5 F), whereas at 72hpf the expression levels of cyclinB and cyclinD are 
significantly higher (Fig. 5 G).   
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DISCUSSION 
  In this study, we evaluated the function of the microglia-specific growth factor, 
Pgrn-a. Knockdown of Pgrn-a significantly altered neurogenesis; retinal progenitors do 
not exit the cell cycle at the appropriate developmental time, and neuronal differentiation 
and early retinal and ocular growth is delayed. Further, knockdown of Pgrn-a results in a 
significant lengthening the cell cycle. These data  serve as the mechanistic explanation 
for the delay in retinal development, and demonstrate that Pgrn-a plays a fundamental 
role in governing early neurogenic events by regulating the brain’s intrinsic timing of the 
cell cycle. 
Progranulin is a soluble growth factor that has multiple functions in developing 
and adult vertebrates. In vitro, PGRN promotes migration and invasiveness of 
transformed cells (Tangkeangsirisin and Serrero, 2004; Monami et al., 2006; Swamydas 
et al., 2011; Dong et al., 2015), stimulates proliferation and migration of endothelial and 
fibroblast cells (Bateman and Bennett, 2009), and acts as a chemoattractant to 
microglia (Pickford et al., 2011). In vivo, application of PGRN to a cutaneous wound 
results in an increase in macrophage, neutrophil, and blood vessel accumulation in the 
wound (He et al., 2003). In humans, macrophage infiltration into adipose tissues 
correlates with circulating PGRN, further suggesting PGRN acts as a macrophage 
chemotactic factor (Youn et al., 2009). Our data are the first to demonstrate Pgrn-a 
regulates the migration of microglial precursors, originating in the rostral blood island 
(RBI; Xu et al., 2015a,b), into neuroepithelial tissues and, therefore, acts as a 
chemoattractant to microglia in vivo. We hypothesize that during early zebrafish 
embryogenesis, the developing forebrain serves as a source of Pgrn-a, thereby 
establishing a morphogenic gradient between the brain and yolk sac. Microglial 
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precursors migrate up the Pgrn-a gradient. Consistent with our hypothesis, depleting 
Pgrn-a significantly decreases the number of microglia that invade the retina. In the 
mRNA rescue experiments, exogenous pgrn-a (or pgrn-b) is ubiquitously expressed in 
every cell. While this restores the function of Pgrn-a during retinal neurogenesis, there 
is no discrete source of Pgrn-a protein that is sufficient to recreate a gradient and, 
thereby, fully rescue the migration of microglia into the retina. Together, these data 
suggest that, similar to in vitro results (Pickford et al., 2011), in vivo, Pgrn-a acts as a 
chemoattractant and directs microglial migration into neuroepthelial tissues.  
 Progranulin was first identified as a novel autocrine epithelial cell growth factor in 
peripheral tissues (Review by Bateman and Bennett, 1998). Subsequent studies have 
shown that in humans Progranulin is involved in both neurodegeneration and 
glioblastoma (De Muynck and Van Damme, 2011). PGRN was first identified as a 
mitogen in the tumorigenic PC cell line (Zhou et al., 1993). Later studies established 
that the level of PGRN expression is directly proportional to proliferation rate of cells in 
vitro and tumorigenicity in vivo, such that increased PGRN levels accelerates cell 
division (He and Bateman, 1999), and decreased PGRN levels attenuates tumor growth 
(Zhang and Serrero, 1998). Acting as both a competence and progression factor, PGRN 
promotes mitosis in embryonic and adult epithelial cells by stimulating classic growth 
factor signal transduction cascades, such as mitogen-activated protein kinase 
(MAPK)/extracellular-signal-related kinase (ERK) and phosphatidylinositol 3-kinase 
(PI3K) pathways (Reviewed by Ong and Bateman, 2003; Bateman and Bennett, 2009). 
Modulation of PGRN levels within the CNS appears similarly to affect cell cycle activity. 
Our data demonstrates that among retinal progenitors in vivo Pgrn-a promotes 
progression through the cell cycle. Pgrn-a knockdown results in a significant 
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lengthening of the cell cycle. Further, when Pgrn-a is reduced, the number of retinal 
progenitors exiting the cell cycle and undergoing terminal differentiation is significantly 
decreased. In Pgrn-a morphants, mitotically active cells take longer to transit G1 and G2 
and undergo mitosis. Overall, these data indicate that in retinal progenitors Pgrn-a 
governs the duration of the G1-, G2- and M-phases of the cell cycle. Therefore, Pgrn-a 
normally functions to promote cell cycle progression and neuronal differentiation in the 
developing retina. This illustrates that Pgrn-a functions similarly in peripheral tissues 
and in the CNS by driving cells through the cell cycle. The cell cycle data were analyzed 
at a stage when all neural progenitors express pgrn-a, and suggest that among these 
cells Pgrn-a may function as either an autocrine or paracrine growth factor. In contrast, 
starting at 36-48hpf, when Pgrn-a expression can be ascribed solely to microglia, the 
changes in cell cycle kinetics likely reflect the consequence of the absence of Pgrn-a in 
microglia.  
 We found that Pgrn-a also governs migration of microglial precursors into the 
embryonic brain. Though the ontogeny of microglia was debated for many years 
(Reviewed in Cuadros and Navascués, 2001; Ginhoux and Prinz, 2015), it is now 
established in fish (Herbomel, 2001), birds (Cuadros et al., 1993), and rodents (Ginhoux 
et al., 2010) that embryonic microglia originate as primitive yolk sac macrophages. In 
zebrafish, macrophages/microglial precursors migrate from the embryonic RBI (Xu et al., 
2015a,b) into head mesenchyme between 22-40hpf, colonize neuroepithelial tissues, 
including the retina, between 30-48hpf, then undergo a phenotypic transformation 
around 60hpf to adopt their final microglial state (Herbomel et al., 1999; Herbomel, 
2001). The migration of macrophages/microglial precursors into the developing CNS is 
also highly conserved across vertebrate species (fish: Herbomel, 2001; rodents: 
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Swinnen et al., 2013; humans: Verney et al., 2010). Although the mechanisms that 
regulate microglial migration and maturation are not completely understood, these 
processes depend on multiple factors and are critical for normal CNS development and 
function (Reviewed in Nayak et al., 2014; Prinz and Priller, 2014). In vertebrates, 
microglia govern early neurogenic events. When microglial precursors fail to colonize 
the CNS, developmental neurogenesis is aberrant. Mice that completely lack CNS 
microglia have multiple developmental brain abnormalities, including small brains, 
increased neuronal density and decreased cortical thickness (Ginhoux et al., 2010; 
Erblich et al., 2011; Nandi et al., 2012). These animals do not live beyond one month of 
age (Dai et al., 2004).  
 There are numerous factors that regulate microglial migration in the developing 
zebrafish. Cell autonomous factors, such as the Leucine/Arginine transporter, slc7a7 
(Rossi et al., 2015b), phosphate exporter XPR1 orthologue, xpr1b (Meireles et al., 
2014), and noncanonical NOD-like receptor, nlrc3-like (Shiau et al., 2013), are required 
for primitive macrophage migration to and colonization of embryonic neuroepithelial 
tissues. Zebrafish slc7a7, xpr1b, and nlrc3-like mutants all lack microglia (Shiau et al., 
2013; Meir les et al., 2014; Rossi et al., 2015), though the embryonic retinal and brain 
phenotypes among these mutants remain to be determined. Non-cell autonomous 
factors produced by neuroepithelial tissues, such as cell death signals and chemokines, 
also promote macrophage chemotaxis during development of the brain and retina 
(Reviewed in Polazzi and Contestabile, 2002; Schwarz and Bilbo, 2013). Two recent 
studies demonstrate that in zebrafish apoptotic neurons and the molecules they release 
mediate the entry of microglial precursors into the optic tectum and their in situ 
proliferation (Xu et al., 2015b; Casano et al., 2016). These studies show that the tectal 
Page 22 of 42
John Wiley & Sons, Inc.
Developmental Neurobiology
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 23
apoptosis that guides microglial colonization begins around 48hpf and peaks at 72hpf. 
Interestingly, this developmental cell death follows the expression of Pgrna in neural 
progenitors. This suggests a complex of signaling cascades (see above), where Pgrna 
provides signals that elicit the initial migration of microglia precursors into the brain, and 
neuronal cell death then sustains microglia colonization and mediates their spatial 
position and initial number.  
Members of the zebrafish community have recently expressed concerns 
regarding the use of MOs as experimental tools (Schulte-Merker and Stainier, 2014), 
and some have declared data based on MOs untrustworthy (Kok et al., 
2015). Nonetheless, we are confident in the data presented here that are based on MO-
induced knockdown of Pgrn-a. First, we used two independent MOs that targeted 
different regions of pgrn-a, and each MO produced essentially identical results. Second, 
we confirmed specific knockdown of Pgrn-a protein by Western blot analysis. Third, we 
used low, minimum doses of MOs: 0.25ng and 1ng for the 5’UTR and SS MO, 
respectively. Fourth, we co-injected each experimental MO with a p53-targeting MO to 
suppress p53 activity and minimize off target/non-specific effects, including ectopic cell 
death. Fifth, we characterized the retinal phenotype in morphants at 72hpf, a time at 
which the MO-induced knockdown and the concentration of MOs in individual cells is 
nearing its effective limit (unpublished observations; Bill et al., 2009). Finally, co-
injecting Pgrn mRNA uniformly rescued the morphant phenotype, which validates the 
specificity of the MOs and the relationship between Pgrn-a knockdown and the retinal 
phenotype. Together, these observations support the data presented here and suggest 
that, when used at limiting doses and rigorously controlled, MOs have a place in the 
repertoire of zebrafish biologists.  
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Finally,  zebrafish mutant for pgrn-a and pgrn-b were recently generated using 
zinc finger nuclease genome editing technology (Solchenberger et al., 2015). Neither 
single or double pgrn mutants recapitulated the spinal motor neuron axonopathy 
observed (Laird et al., 2010) or the diminished proliferation among myogenic progenitor 
cells reported (Li et al., 2013) following MO-induced knockdown of Pgrn-a. (Retinal 
development was not evaluated in the pgrn-a mutants.) The absence of concordance 
between knockdown and mutant phenotypes may be explained by the recent 
observation that targeted genetic mutations in zebrafish can result in genetic 
compensation by signaling molecules in related pathways that selectively mask loss-of-
function mutations (Rossi et al., 2015a). Though the field awaits a fuller description of 
the pgrn mutants, the morphant data presented here can safely be interpreted to show 
that Pgrn-a protein plays a fundamental role in governing developmental neurogenesis 
by regulating cell cycle kinetics and microglial precursor migration. Further assessment 
of the function of Pgrn-a in governing microglia behavior during retinal development and 
regeneration will require transgenic report lines that faithfully label both microglia 
precursors and mature microglia.  
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FIGURE LEGENDS 
 
Figure 1: Expression of pgrn-a in the developing retina. (A-D) Cross-sections of the 
retina following whole mount in situ hybridizations showing pgrn-a expression in WT at 
24 (A), 36 (B), 48 (C), and 72hpf (D). (E-L) pgrn-a is microglia-specific by 72hpf. pgrn-a 
in situ hybridization (E+G) followed by immunohistochemistry of L-plastin (F) and 4C4 
(H) showing co-localization of pgrn-a and microglial markers (arrowheads). Double in 
situ hybridization in the same section showing DAPI (I), pgrn-a (J), and fms (K) 
expression, and overlay (L) showing co-localization of pgrn-a and fms in the retina 
(arrowheads). In panel D, it appears there is transcript expression in the CMZ. However, 
there is no evidence for this following whole mount ISH (see Fig. S1), and we infer that 
in sections this apparent labeling is spurious. Outer nuclear layer (ONL); inner nuclear 
layer (INL); and ganglion cell layer (GCL); (L) lens. Scale bar equals 50µm. 
 
Figure 2: pgrn-a-targeted morpholino oligonucleotides inhibit Pgrn-a translation, 
which results in microphthalmia. (A) Western blot showing Pgrn-a and Actin 
expression in 72hpf uninjected (UI) and morphant (5’UTR MO) embryos. (B) Histogram 
showing quantification of Pgrn-a expression in UI controls (26.2 ± 2.05%) and 
morphants (2.7 ± 0.9%); **p≤0.01. Quantitative data from three biological and technical 
replicates is normalized to Actin and represented as mean; error bars represent the 
standard deviation. (C-H) Representative whole embryos from control (C-F) and 
experimental (G-H) groups at 72hpf. 5’UTR MM MO and SS MM MO, embryos injected 
with 5-nucleotide mismatch control morpholinos; 5’UTR MO, embryos injected with 
pgrn-a 5’UTR-targeted morpholinos; SS MO, embryos injected with pgrn-a e3i3 splice 
site-targeted morpholinos.  
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Figure 3: Pgrn-a knockdown results in microphthalmia and diminished neuronal 
differentiation. (A-R) Sections through central retina of uninjected (UI, A-C); standard 
control morpholino-injected (SC, D-F); SS MM (G-I) and 5’UTR MM (J-L), embryos 
injected with 5-nucleotide mismatch control morpholinos; SS MO (M-O) and 5’UTR MO 
(P-R), embryos injected with e3i3 splice site-targeted or 5’UTR-targeted morpholinos, 
respectively, at 72hpf. Sections are immunolabeled (cyan) with markers of differentiated 
ganglion cells (Zn5, top row), amacrine cells (HPC1, middle row), and red-green double 
cone photoreceptor cells (ZPR1, bottom row), EdU (fusia), and DAPI (gray). (S) 
Histogram showing relative retinal area in UI (7945.8 ± 1319.6 µm2; n=11; CI, 7945 ± 
886), SC-injected (7594.3 ± 475.2 µm2; n=9; CI, 7594 ± 365), SS MM MO-injected 
(7354 ± 1062.6 µm2; n=11; CI, 7353 ± 713), and 5’UTR MM MO-injected (7610.8 ± 
547.6 µm2; n=10; CI, 7610 ± 391), SS MO (6044.7 ± 956.2 µm2; n=10; CI, 6044 ± 684), 
and 5’UTR MO (5188.7 ± 891.8 µm2; n=16; CI, 5188 ± 475) retinas at 72hpf; ***p≤0.001. 
(T) Histogram showing the percent of the retina labeled with EdU in UI (9.3 ± 4.3%; 
n=11; CI, 9.3 ± 2.9), SC-injected (12 ± 3.1%; n=9; CI, 12.0 ± 3.3), SS MM MO-injected 
(10.8 ± 3.5%; n=11; CI, 10.8 ± 2.1), 5’UTR MM MO-injected (9.8 ± 2.3%; n=10; CI, 9.8 ± 
2.5), SS MO-injected (27.5 ± 11.5%; n=10; CI, 27.6 ± 1.7), and 5’UTR MO-injected 
(41.1 ± 13%; n=16; CI, 41.1 ± 6.1) retinas at 72hpf; ***p≤0.001. (U) Histogram showing 
the number of microglia in uninjected (UI; 55.4 ± 21.5 cells; n=20; CI, 62.4 ± 10.7), 
5’UTR mismatch morpholino injected (5’UTR MM; 43.4 ± 4.6 cells; n=8; CI, 43.4 ± 3.8), 
and Pgrn-a morphant (5’UTR MO; 4.4 ± 3.4 cells; n=11; CI, 4.4 ± 2.3) retinas at 72hpf; 
***p≤0.001. Quantitative data are represented as mean; error bars represent the 
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standard deviation. Outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion 
cell layer (GCL); ciliary marginal zone (CMZ, brackets). Scale bar equals 50µm.  
 
Figure 4: Co-injection of 5’UTR MO and zf pgrn-a, zf pgrn-b, or hGRN mRNA 
rescues most aspects of knockdown retinal phenotype. (A-O) Cross-sections 
through central retina of 72hpf uninjected (UI, A-C), 5’UTR MO-injected (D-F), 5’UTR 
MO and zf pgrn-a mRNA co-injected (G-I), 5’UTR MO and zf pgrn-b mRNA co-injected 
(J-L), and 5’UTR MO and hGRN mRNA co-injected (M-O) embryos at 72 hpf. Sections 
are immunolabeled (cyan) with markers for ganglion cells (Zn-5, left column), red-green 
double cone photoreceptors (Zpr1, middle column), and amacrine cells (HPC1, right 
column), EdU (fusia), and DAPI (gray). (P) Histogram showing relative retinal area of UI 
(17437.4 ± 2286.1 µm2; n=23; CI, 16970 ± 2226), 5’UTR MO-injected (12961.2 ± 2251.8 
µm2; n=21; CI, 11329 ± 768), 5’UTR MO and eGFP mRNA co-injected (10809 ± 2282.5 
µm2; n=8; CI, 14374 ± 1775), 5’UTR MO and zf pgrn-a mRNA co-injected (16435.7 ± 
2882.2 µm2; n=12; CI, 16860 ± 1163), 5’UTR MO and zf pgrn-b mRNA co-injected 
(15357.8 ± 2750.2 µm2; n=13; CI, 14834 ± 1305), and 5’UTR MO and hGRN mRNA co-
injected (17146.1 ± 2930.7 µm2; n=12; CI 18579 ± 1405) embryos at 72hpf; ***p<0.001. 
(Q) Histogram showing the percent of the retina labeled with EdU in UI (10.5 ± 3.9%; 
n=7; CI, 11.0 ± 4.0), 5’UTR MO-injected (45 ± 7.9%; n=18; CI, 45 ± 4.0), 5’UTR MO and 
eGFP mRNA co-injected (41.1 ± 4.5%; n=6; CI, 41.0 ± 5.0), 5’UTR MO and zf pgrn-a 
mRNA co-injected (15.2 ± 6.8%; n=22; CI, 15.0 ± 3.0), 5’UTR MO and zf pgrn-b mRNA 
co-injected (20.8 ± 9.6%; n=18; CI, 21 ± 5.0), and 5’UTR MO and hGRN mRNA co-
injected (21.8 ± 8.5%; n=12; CI, 15 ± 6.0) embryos at 72hpf; ***p<0.001. (R) Histogram 
showing the number of retinal microglia (4C4+ cells) at 72hpf in UI (95 ± 30.5 cells; 
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n=23; CI, 95.0 ± 12.5), 5’UTR MO-injected (8.4 ± 6.8 cells; n=21; CI, 8.4 ± 2.9), 5’UTR 
MO and eGFP mRNA co-injected (5.4 ± 4.8 cells; n=8; CI, 5.4 ± 3.3), 5’UTR MO and zf 
pgrn-a mRNA co-injected (17.7 ± 10.2 cells; n=12; CI, 17.7 ± 5.8), 5’UTR MO and zf 
pgrn-b mRNA co-injected (28.9 ± 14.7 cells; n=13; CI, 28.9 ± 8.0), and 5’UTR MO and 
hGRN mRNA co-injected (20.6 ± 10.8; n=12; CI, 20.6 ± 6.1) embryos; ***p<0.001. 
Quantitative data are represented as mean; error bars represent the standard deviation. 
Outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL); 
ciliary marginal zone (CMZ, brackets). Scale bar equals 50µm. 
 
Figure 5: Knockdown of pgrn-a alters cell cycle kinetics in retinal progenitors. (A) 
Representative retinal sections from 28hpf uninjected (left panel), MM MO (center 
panel), and 5’UTR MO (right panel) embryos stained with antibodies against pH3 
(green), BrdU (fusia), and DAPI (blue) used for quantification of mitotic index. (B) 
Histogram showing the mitotic index at 28hpf. The number of pH3+ cells/unit area in UI 
(0.0002 ± 1.973e-005 cells per µm2; n=11; CI, .0002 ± 3.8e-3.9), MM MO (0.0002 ± 
1.947e-005 cells per µm2; n=10; CI, .0002 ± 3.8e-05), and 5’UTR MO retinas (0.0001 ± 
1.366e-005 cells per µm2; n=10; CI, .0001 ± 2.7e-05); *p≤0.01. (C) Graph showing the 
percent labeled mitosis for UI, MM MO and 5’UTR MO embryos between 28 and 35hpf. 
(D) Histogram showing average S-phase length (TS) in 26-28hpf UI (6.4 ± 2.8hrs; n=16; 
CI, 6.4 ± 1.4), MM MO (5.9 ± 3.0hrs; n=10; CI, 6.0 ± 1.8), and 5’UTR MO (6.0 ± 2.9hrs; 
n=7; CI, 6.0 ± 2.1) embryos. (E) Histogram showing average total cell cycle length (TC) 
at 26-28hpf in UI (9.9 ± 2.2hrs; n=16; CI, 9.9 ± 1.1), MM MO (9.3 ± 2.5hrs; n=10; CI, 9.3 
± 1.5), and 5’UTR MO (13.5 ± 5.2hrs; n=7; CI, 13.5 ± 3.9); *p≤0.05. F-G) Histograms 
showing relative cyclin B (ccnb1), cyclin D (ccnd1), cyclin E (ccne1), p27kip and p57kip 
Page 35 of 42
John Wiley & Sons, Inc.
Developmental Neurobiology
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 36
mRNA expression normalized to beta actin at 30hpf (F) and 72hpf (G); *p≤0.05 and 
**p≤0.01. Quantitative data are represented as mean; error bars represent the standard 
deviation. Scale bar = 50µm. 
 
Supplemental Figure 1: Developmental expression pattern of pgrn-a in whole 
embryos and Western blot of Pgrn-a expression at 24hpf. (A-D) Whole mount in situ 
hybridization showing pgrn-a expression in wild type (WT) at 24 (A), 48 (B), and 72hpf 
(arrowheads in C+D). Panel D is a higher magnification image of the eye in panel C. In 
each panel, the dashed line marks the boundary of the eye. Lens (L). (E) Western blot 
showing Pgrn-a and Actin expression in 24hpf AB WT embryos.  
 
Supplemental Figure 2: Aspects of Pgrn-a knockdown retinal phenotype recover 
by 8dpf. (A) Sections through central retina of uninjected (UI, left column), 5’UTR MM 
MO (middle column), and 5’UTR MO (right column) larvae at 8dpf, immunolabeled 
(cyan) with markers of red-green cone photoreceptors (ZPR1, top row) and amacrine 
cells (HCP1, middle row), BrdU (fusia, bottom row), and DAPI (gray). (B) Histogram 
showing th  size of the retina in UI (21533.35 ± 4112.8 µm2; n=15: CI, 21533.4 
±2277.6), 5’UTR MM MO (22360.0 ± 4324.0 µm2; n=9; CI, 22360 ± 3323.7), and 5’UTR 
MO (15000.4 ± 3861.2 µm2; n=15; CI, 15000.4 ± 2138.3) larvae at 8dpf; ***p<0.001. (C) 
Histogram showing the number of retinal microglia (4C4+ cells) in UI (95.2 ± 24.7 cells; 
n=15; CI, 95.2 ± 13.7), 5’UTR MM MO (100 ± 31.7 cells; n=9; CI, 100 ± 24.37), and 
5’UTR MO (26.1 ± 8.5 cells; n=15; CI, 26.1 ± 7.2) larvae at 8dpf; ***p<0.001. 
Quantitative data are represented as mean; error bars represent the standard deviation. 
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Outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL). 
Scale bar equals 100µm. 
 
Supplemental Figure 3: Normal onset of atoh7 expression in control and 
morphant embryos. Whole mount in situ hybridization showing atoh7 expression in 
uninjected (A), 5’UTR MM MO (B), and 5’UTR MO (C) embryos at 28hpf. (D) Histogram 
showing the number of TUNEL-positive cells in uninjected (28 hpf: 8.2 ± 3.3; n=10; CI, 
8.2 ± 2.4; 48hpf: 8.2 ± 4.2; n=9; CI, 8.2 ± 3.2), MM MO-injected (28hpf: 7.1 ± 4.0; n=10; 
CI, 7.1 ± 4.0; 48hpf: 4.4 ± 3.4; n=5; CI 4.2 ± 4.4), and 5’UTR MO-injected (28hpf: 4.8 ± 
3.8; n=9; CI, 4.8 ± 3.0; 48hpf: 6.5 ± 4.3; n=10; CI, 6.5 ± 3.1) retinas at 28 and 48hpf, 
respectively (p>0.05).  
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Figure 1. Expression of pgrn-a in the developing retina. (A-D) Cross-sections of the retina following whole 
mount in situ hybridizations showing pgrn-a expression in WT at 24 (A), 36 (B), 48 (C), and 72hpf (D). (E-L)
pgrn-a is microglia-specific by 72hpf. pgrn-a in situ hybridization (E+G) followed by immunohistochemistry 
of L-plastin (F) and 4C4 (H) showing co-localization of pgrn-a and microglial markers (arrowheads). Double 
in situ hybridization in the same section showing DAPI (I), pgrn-a (J), and fms (K) expression, and overlay 
(L) showing co-localization of pgrn-a and fms in the retina (arrowheads). In panel D, it appears there is 
transcript expression in the CMZ. However, there is no evidence for this following whole mount ISH (see Fig. 
S1), and we infer that in sections this apparent labeling is spurious. Outer nuclear layer (ONL); inner nuclear 
 layer (INL); and ganglion cell layer (GCL); (L) lens. Scale bar equals 50µm.   
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Figure 2. pgrn-a-targeted morpholino oligonucleotides inhibit Pgrn-a translation, which results in 
microphthalmia. (A) Western blot showing Pgrn-a and Actin expression in 72hpf uninjected (UI) and 
morphant (5’UTR MO) embryos. (B) Histogram showing quantification of Pgrn-a expression in UI controls 
(26.2 ± 2.05%) and morphants (2.7 ± 0.9%); **p≤0.01. Quantitative data from three biological and 
technical replicates is normalized to Actin and represented as mean; error bars represent the standard 
deviation. (C-H) Representative whole embryos from control (C-F) and experimental (G-H) groups at 72hpf. 
5’UTR MM MO and SS MM MO, embryos injected with 5-nucleotide mismatch control morpholinos; 5’UTR MO, 
embryos injected with pgrn-a 5’UTR-targeted morpholinos; SS MO, embryos injected with pgrn-a e3i3 splice 
site-  targeted morpholinos.   
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Figure 3: Pgrn-a knockdown results in microphthalmia and diminished neuronal differentiation. (A-R) 
Sections through central retina of uninjected (UI, A-C); standard control morpholino-injected (SC, D-F); SS 
MM (G-I) and 5’UTR MM (J-L), embryos injected with 5-nucleotide mismatch control morpholinos; SS MO 
(M-O) and 5’UTR MO (P-R), embryos injected with e3i3 splice site-targeted or 5’UTR-targeted morpholinos, 
respectively, at 72hpf. Sections are immunolabeled (cyan) with markers of differentiated ganglion cells 
(Zn5, top row), amacrine cells (HPC1, middle row), and red-green double cone photoreceptor cells (ZPR1, 
bottom row), EdU (fusia), and DAPI (gray). (S) Histogram showing relative retinal area in UI (7945.8 ± 
1319.6 µm2; n=11; CI, 7945 ± 886), SC-injected (7594.3 ± 475.2 µm2; n=9; CI, 7594 ± 365), SS MM 
MO-injected (7354 ± 1062.6 µm2; n=11; CI, 7353 ± 713), and 5’UTR MM MO-injected (7610.8 ± 547.6 
µm2; n=10; CI, 7610 ± 391), SS MO (6044.7 ± 956.2 µm2; n=10; CI, 6044 ± 684), and 5’UTR MO 
(5188.7 ± 891.8 µm2; n=16; CI, 5188 ± 475) retinas at 72hpf; ***p≤0.001. (T) Histogram showing the 
percent of the retina labeled with EdU in UI (9.3 ± 4.3%; n=11; CI, 9.3 ± 2.9), SC-injected (12 ± 3.1%; 
n=9; CI, 12.0 ± 3.3), SS MM MO-injected (10.8 ± 3.5%; n=11; CI, 10.8 ± 2.1), 5’UTR MM MO-injected 
(9.8 ± 2.3%; n=10; CI, 9.8 ± 2.5), SS MO-injected (27.5 ± 11.5%; n=10; CI, 27.6 ± 1.7), and 5’UTR MO-
injected (41.1 ± 13%; n=16; CI, 41.1 ± 6.1) retinas at 72hpf; ***p≤0.001. (U) Histogram showing the 
number of microglia in uninjected (UI; 55.4 ± 21.5 cells; n=20; CI, 62.4 ± 10.7), 5’UTR mismatch 
morpholino injected (5’UTR MM; 43.4 ± 4.6 cells; n=8; CI, 43.4 ± 3.8), and Pgrn-a morphant (5’UTR MO; 
4.4 ± 3.4 cells; n=11; CI, 4.4 ± 2.3) retinas at 72hpf; ***p≤0.001. Quantitative data are represented as 
mean; error bars represent the standard deviation. Outer nuclear layer (ONL), inner nuclear layer (INL), and 
ganglion cell layer (GCL); ciliary marginal zone (CMZ, brackets). Scale bar equals 50µm.  
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Figure 4: Co-injection of 5’UTR MO and zf pgrn-a, zf pgrn-b, or hGRN mRNA rescues most aspects of 
knockdown retinal phenotype. (A-O) Cross-sections through central retina of 72hpf uninjected (UI, A-C), 
5’UTR MO-injected (D-F), 5’UTR MO and zf pgrn-a mRNA co-injected (G-I), 5’UTR MO and zf pgrn-b mRNA 
co-injected (J-L), and 5’UTR MO and hGRN mRNA co-injected (M-O) embryos at 72 hpf. Sections are 
immunolabeled (cyan) with markers for ganglion cells (Zn-5, left column), red-green double cone 
photoreceptors (Zpr1, middle column), and amacrine cells (HPC1, right column), EdU (fusia), and DAPI 
(gray). (P) Histogram showing relative retinal area of UI (17437.4 ± 2286.1 µm2; n=23; CI, 16970 ± 
2226), 5’UTR MO-injected (12961.2 ± 2251.8 µm2; n=21; CI, 11329 ± 768), 5’UTR MO and eGFP mRNA 
co-injected (10809 ± 2282.5 µm2; n=8; CI, 14374 ± 1775), 5’UTR MO and zf pgrn-a mRNA co-injected 
(16435.7 ± 2882.2 µm2; n=12; CI, 16860 ± 1163), 5’UTR MO and zf pgrn-b mRNA co-injected (15357.8 ± 
2750.2 µm2; n=13; CI, 14834 ± 1305), and 5’UTR MO and hGRN mRNA co-injected (17146.1 ± 2930.7 
µm2; n=12; CI 18579 ± 1405) embryos at 72hpf; ***p<0.001. (Q) Histogram showing the percent of the 
retina labeled with EdU in UI (10.5 ± 3.9%; n=7; CI, 11.0 ± 4.0), 5’UTR MO-injected (45 ± 7.9%; n=18; 
CI, 45 ± 4.0), 5’UTR MO and eGFP mRNA co-injected (41.1 ± 4.5%; n=6; CI, 41.0 ± 5.0), 5’UTR MO and zf 
pgrn-a mRNA co-injected (15.2 ± 6.8%; n=22; CI, 15.0 ± 3.0), 5’UTR MO and zf pgrn-b mRNA co-injected 
(20.8 ± 9.6%; n=18; CI, 21 ± 5.0), and 5’UTR MO and hGRN mRNA co-injected (21.8 ± 8.5%; n=12; CI, 
15 ± 6.0) embryos at 72hpf; ***p<0.001. (R) Histogram showing the number of retinal microglia (4C4+ 
cells) at 72hpf in UI (95 ± 30.5 cells; n=23; CI, 95.0 ± 12.5), 5’UTR MO-injected (8.4 ± 6.8 cells; n=21; 
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CI, 8.4 ± 2.9), 5’UTR MO and eGFP mRNA co-injected (5.4 ± 4.8 cells; n=8; CI, 5.4 ± 3.3), 5’UTR MO and 
zf pgrn-a mRNA co-injected (17.7 ± 10.2 cells; n=12; CI, 17.7 ± 5.8), 5’UTR MO and zf pgrn-b mRNA co-
injected (28.9 ± 14.7 cells; n=13; CI, 28.9 ± 8.0), and 5’UTR MO and hGRN mRNA co-injected (20.6 ± 
10.8; n=12; CI, 20.6 ± 6.1) embryos; ***p<0.001. Quantitative data are represented as mean; error bars 
represent the standard deviation. Outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell 
layer (GCL); ciliary marginal zone (CMZ, brackets). Scale bar equals 50µm. 
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Figure 5: Knockdown of pgrn-a alters cell cycle kinetics in retinal progenitors. (A) Representative retinal 
sections from 28hpf uninjected (left panel), MM MO (center panel), and 5’UTR MO (right panel) embryos 
stained with antibodies against pH3 (green), BrdU (fusia), and DAPI (blue) used for quantification of mitotic 
index. (B) Histogram showing the mitotic index at 28hpf. The number of pH3+ cells/unit area in UI (0.0002 
± 1.973e-005 cells per µm2; n=11; CI, .0002 ± 3.8e-3.9), MM MO (0.0002 ± 1.947e-005 cells per µm2; 
n=10; CI, .0002 ± 3.8e-05), and 5’UTR MO retinas (0.0001 ± 1.366e-005 cells per µm2; n=10; CI, .0001 ± 
2.7e-05); *p≤0.01. (C) Graph showing the percent labeled mitosis for UI, MM MO and 5’UTR MO embryos 
between 28 and 35hpf. (D) Histogram showing average S-phase length (TS) in 26-28hpf UI (6.4 ± 2.8hrs; 
n=16; CI, 6.4 ± 1.4), MM MO (5.9 ± 3.0hrs; n=10; CI, 6.0 ± 1.8), and 5’UTR MO (6.0 ± 2.9hrs; n=7; CI, 
6.0 ± 2.1) embryos. (E) Histogram showing average total cell cycle length (TC) at 26-28hpf in UI (9.9 ± 
2.2hrs; n=16; CI, 9.9 ± 1.1), MM MO (9.3 ± 2.5hrs; n=10; CI, 9.3 ± 1.5), and 5’UTR MO (13.5 ± 5.2hrs; 
n=7; CI, 13.5 ± 3.9); *p≤0.05. F-G) Histograms showing relative cyclin B (ccnb1), cyclin D (ccnd1), cyclin 
E (ccne1), p27kip and p57kip mRNA expression normalized to beta actin at 30hpf (F) and 72hpf (G); 
*p≤0.05 and **p≤0.01. Quantitative data are represented as mean; error bars represent the standard 
deviation. Scale bar = 50µm. 
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